Document:

EX-10.52

   

  Exhibit 10.52

  CARIBOU BIOSCIENCES, INC.

  2021 EQUITY INCENTIVE PLAN

  RESTRICTED STOCK UNIT AWARD GRANT NOTICE

  Caribou Biosciences, Inc., a Delaware corporation (the “Company”), pursuant to its 2021 Equity Incentive Plan (the “Plan”), hereby grants to the holder listed below (the “Participant”), an award of restricted stock units (“Restricted Stock Units” or “RSUs”). Each vested Restricted Stock Unit represents the right to receive, in accordance with the Restricted Stock Unit Award Agreement attached hereto as Exhibit A (the “Agreement”), one share of Common Stock (“Share”). This award of Restricted Stock Units is subject to all of the terms and conditions set forth herein and in the Agreement and the Plan, each of which are incorporated herein by reference. Unless otherwise defined herein, the terms defined in the Plan shall have the same defined meanings in this Restricted Stock Unit Award Grant Notice (the “Grant Notice”) and the Agreement.

   

  			
	 
	 
	 

	Participant:
	 
	%%FIRST_NAME_MIDDLE_NAME_LAST_NAME%-%                  

	 
	 

	Grant Date:
	 
	%AWARD_DATE,'Month DD, YYYY'%-%

	 
	 

	Total Number of RSUs:
	 
	%%TOTAL_SHARES_GRANTED,'999,999,999'%-%

	 
	 

	Vesting Commencement Date:
	 
	%%VEST_BASE_DATE,'Month DD, YYYY'%-%

	 
	 

	Vesting Schedule:
	 
	 

	 
	 
	Twenty-five percent (25%) of the Shares subject to the RSU shall vest on each of the one (1), two (2), three (3), and four (4) year anniversaries of the Vesting Commencement Date, subject to Participant continuing to be an Employee through each such date. On each vesting date, the number of Shares vesting shall be rounded down to the nearest whole share, with the balance vesting on the last vesting date.

	 
	 

	Termination:
	 
	If the Participant experiences a Termination of Service, all RSUs that have not become vested on or prior to the date of such Termination of Service will thereupon be automatically forfeited by the Participant without payment of any consideration therefor.

   

   

   

   

   

   

   

  - 1 -

   

  

   

   

   

   

   

  By their signature and the Company’s signature below, the Participant agrees to be bound by the terms and conditions of the Plan, the Agreement and this Grant Notice. The Participant has reviewed the Agreement, the Plan and this Grant Notice in their entirety, has had an opportunity to obtain the advice of counsel prior to executing this Grant Notice and fully understands all provisions of this Grant Notice, the Agreement, and the Plan. The Participant hereby agrees to accept as binding, conclusive, and final all decisions or interpretations of the Administrator upon any questions arising under the Plan, this Grant Notice, or the Agreement. In addition, by signing below, the Participant also agrees that the Company, in its sole discretion, may satisfy any withholding obligations in accordance with Section 2.6(b) of the Agreement by (i) withholding shares of Common Stock otherwise issuable to the Participant upon vesting of the RSUs, (ii) instructing a broker on the Participant’s behalf to sell shares of Common Stock otherwise issuable to the Participant upon vesting of the RSUs and submit the proceeds of such sale to the Company, or (iii) using any other method permitted by Section 2.6(b) of the Agreement or the Plan.

  									
	 
	 
	 
	 
	 
	 
	 
	 
	 

	 
	 
	 
	 
	 

   

   

  					
	 
	 
	 
	 
	 

	PARTICIPANT
	   
	         
	  
	CARIBOU BIOSCIENCES, INC.

	 
	 
	 

	Signature
	   
	 
	  
	By

	 
	 
	 

	%%FIRST_NAME_MIDDLE_NAME_LAST_NAME%-%
	   
	 
	  
	/s/ Rachel E. Haurwitz

	Print Name
	 
	 

	%%ADDRESS_LINE_1%-% 
%%ADDRESS_LINE_2%-% 
%%ADDRESS_LINE_3%-%
%%COUNTRY%-%
Residence Address
 
 
	   
	 
	  
	Print Name: Rachel E. Haurwitz, Ph.D.
Title: President & CEO

   

   

   

   

   

   

   

   

   

   

   

   

   

   

   

   

   

   

  - 2 -

   

  

   

   

   

   

   

   

   

   

   

   

   

  EXHIBIT A

  TO RESTRICTED STOCK UNIT AWARD GRANT NOTICE

  RESTRICTED STOCK UNIT AWARD AGREEMENT

  Pursuant to the Restricted Stock Unit Award Grant Notice (the “Grant Notice”) to which this Restricted Stock Unit Award Agreement (this “Agreement”) is attached, Caribou Biosciences, Inc., a Delaware corporation (the “Company”), has granted to the Participant the number of restricted stock units (“Restricted Stock Units” or “RSUs”) set forth in the Grant Notice under the Company’s 2021 Equity Incentive Plan (the “Plan”). Each Restricted Stock Unit represents the right to receive one share of Common Stock (a “Share”) upon vesting. Capitalized terms not specifically defined herein shall have the meanings specified in the Plan and Grant Notice.

   

  ARTICLE I

  GENERAL

  1.1 Incorporation of Terms of Plan. The RSUs are subject to the terms and conditions of the Plan, which are incorporated herein by reference. In the event of any inconsistency between the Plan and this Agreement, the terms of the Plan shall control.

  ARTICLE II

  GRANT OF RESTRICTED STOCK UNITS

  2.1 Grant of RSUs. Pursuant to the Grant Notice and upon the terms and conditions set forth in the Plan and this Agreement, effective as of the Grant Date set forth in the Grant Notice, the Company hereby grants to the Participant an award of RSUs under the Plan in consideration of the Participant’s past and/or continued employment with or service to the Company or any Subsidiaries and for other good and valuable consideration.

  2.2 Unsecured Obligation to RSUs. Unless and until the RSUs have vested in the manner set forth in Article 2 hereof, the Participant will have no right to receive Common Stock under any such RSUs. Prior to actual payment of any vested RSUs, such RSUs will represent an unsecured obligation of the Company, payable (if at all) only from the general assets of the Company.

  2.3 Vesting Schedule. Subject to Section 2.5 hereof, the RSUs shall vest and become nonforfeitable with respect to the applicable portion thereof according to the vesting schedule set forth in the Grant Notice (rounding down to the nearest whole Share). Except as may otherwise be provided in any employment agreement, in the event of any transaction or Change in Control (as defined in the Plan), the RSUs may, in the discretion of the Administrator, be terminated, which may be in exchange for cash or property, be assumed or substituted by the successor corporation or otherwise continued in full force and effect pursuant to the terms of the Change in Control or other transaction on such terms and conditions as the Administrator determines.  

  2.4 Consideration to the Company. In consideration of the grant of the award of RSUs pursuant hereto, the Participant agrees to render faithful and efficient services to the Company or any Subsidiary.

  - 3 -

   

  

   

  2.5 Forfeiture, Termination and Cancellation upon Termination of Service. Notwithstanding any contrary provision of this Agreement or the Plan, upon the Participant’s Termination of Service for any or no reason, all Restricted Stock Units which have not vested prior to or in connection with such Termination of Service shall thereupon automatically be forfeited, terminated and cancelled as of the applicable termination date without payment of any consideration by the Company, and the Participant, or the Participant’s beneficiary or personal representative, as the case may be, shall have no further rights hereunder. No portion of the RSUs which has not become vested as of the date on which the Participant incurs a Termination of Service shall thereafter become vested.

   

   

  2.6 Issuance of Common Stock upon Vesting.

  (a) As soon as administratively practicable following the vesting of any Restricted Stock Units pursuant to Section 2.3 hereof, but in no event later than thirty (30) days after such vesting date (for the avoidance of doubt, this deadline is intended to comply with the “short term deferral” exemption from Section 409A of the Code), the Company shall deliver to the Participant (or any transferee permitted under Section 3.2 hereof) a number of Shares equal to the number of RSUs subject to this Award that vest on the applicable vesting date. 

  (b) As set forth in Section 12.2 of the Plan, the Company shall have the authority and the right to deduct or withhold, or to require the Participant to remit to the Company, an amount sufficient to satisfy all applicable federal, state and local taxes required by law to be withheld with respect to any taxable event arising in connection with the Restricted Stock Units. The Company shall not be obligated to deliver any Shares to the Participant or the Participant’s legal representative unless and until the Participant or the Participant’s legal representative shall have paid or otherwise satisfied in full the amount of all federal, state and local taxes applicable to the taxable income of the Participant resulting from the grant or vesting of the Restricted Stock Units or the issuance of Shares.

  2.7 Conditions to Delivery of Shares. The Shares deliverable hereunder may be either previously authorized but unissued Shares, treasury Shares or issued Shares which have then been reacquired by the Company. Such Shares shall be fully paid and nonassessable. The Company shall not be required to issue Shares deliverable hereunder prior to fulfillment of the conditions set forth in Section 12.4 of the Plan.

  2.8 Rights as Stockholder. The holder of the RSUs shall not be, nor have any of the rights or privileges of, a stockholder of the Company, including, without limitation, voting rights and rights to dividends, in respect of the RSUs and any Shares underlying the RSUs and deliverable hereunder unless and until such Shares shall have been issued by the Company and held of record by such holder (as evidenced by the appropriate entry on the books of the Company or of a duly authorized transfer agent of the Company). No adjustment shall be made for a dividend or other right for which the record date is prior to the date the Shares are issued, except as provided in Section 14.2 of the Plan.

  ARTICLE III

  OTHER PROVISIONS

  3.1 Administration. The Administrator shall have the power to interpret the Plan and this Agreement and to adopt such rules for the administration, interpretation and application of the Plan as are consistent therewith and to interpret, amend or revoke any such rules. All actions taken and all interpretations and determinations made by the Administrator in good faith shall be final and binding upon the Participant, the Company and all other interested persons. No member of the Administrator or the Board shall be personally liable for any action, determination or interpretation made in good faith with respect to the Plan, this Agreement or the RSUs.

  3.2 RSUs Not Transferable. The RSUs shall be subject to the restrictions on transferability set forth in Section 12.3 of the Plan.

  - 4 -

   

  

   

  3.3 Tax Consultation. The Participant understands that the Participant may suffer adverse tax consequences in connection with the RSUs granted pursuant to this Agreement (and the Shares issuable with respect thereto). The Participant represents that the Participant has consulted with any tax consultants the Participant deems advisable in connection with the RSUs and the issuance of Shares with respect thereto and that the Participant is not relying on the Company for any tax advice.

  3.4 Binding Agreement. Subject to the limitation on the transferability of the RSUs contained herein, this Agreement will be binding upon and inure to the benefit of the heirs, legatees, legal representatives, successors and assigns of the parties hereto.

  3.5 Adjustments Upon Specified Events. The Administrator may accelerate the vesting of the RSUs in such circumstances as it, in its sole discretion, may determine. The Participant acknowledges that the RSUs are subject to adjustment, modification and termination in certain events as provided in this Agreement and Section 14.2 of the Plan.

  3.6 Notices. Any notice to be given under the terms of this Agreement to the Company shall be addressed to the Company in care of the Secretary of the Company at the Company’s principal office, and any notice to be given to the Participant shall be addressed to the Participant at the Participant’s last address reflected on the Company’s records. By a notice given pursuant to this Section 3.6, either party may hereafter designate a different address for notices to be given to that party. Any notice shall be deemed duly given when sent via email or when sent by certified mail (return receipt requested) and deposited (with postage prepaid) in a post office or branch post office regularly maintained by the United States Postal Service.

  3.7 Participant’s Representations. If the Shares issuable hereunder have not been registered under the Securities Act or any applicable state laws on an effective registration statement at the time of such issuance, the Participant shall, if required by the Company, concurrently with such issuance, make such written representations as are deemed necessary or appropriate by the Company and/or its counsel.

  3.8 Titles. Titles are provided herein for convenience only and are not to serve as a basis for interpretation or construction of this Agreement.

  3.9 Governing Law. The laws of the State of Delaware shall govern the interpretation, validity, administration, enforcement and performance of the terms of this Agreement regardless of the law that might be applied under principles of conflicts of laws.

  3.10 Conformity to Securities Laws. The Participant acknowledges that the Plan and this Agreement are intended to conform to the extent necessary with all provisions of the Securities Act and the Exchange Act and any other Applicable Law. Notwithstanding anything herein to the contrary, the Plan shall be administered, and the RSUs are granted, only in such a manner as to conform to Applicable Law. To the extent permitted by Applicable Law, the Plan and this Agreement shall be deemed amended to the extent necessary to conform to such Applicable Law.

  3.11 Amendment, Suspension and Termination. To the extent permitted by the Plan, this Agreement may be wholly or partially amended or otherwise modified, suspended or terminated at any time or from time to time by the Administrator or the Board; provided, however, that, except as may otherwise be provided by the Plan, no amendment, modification, suspension or termination of this Agreement shall adversely affect the RSUs in any material way without the prior written consent of the Participant.

  3.12 Successors and Assigns. The Company may assign any of its rights under this Agreement to single or multiple assignees, and this Agreement shall inure to the benefit of the successors and assigns of the Company. Subject to the restrictions on transfer herein set forth in Section 3.2 hereof, this Agreement shall be binding upon the Participant and their heirs, executors, administrators, successors, and assigns.

  3.13 Limitations Applicable to Section 16 Persons. Notwithstanding any other provision of the Plan or this Agreement, if the Participant is subject to Section 16 of the Exchange Act, then the Plan, the RSUs, and this 

  - 5 -

   

  

   

  Agreement shall be subject to any additional limitations set forth in any applicable exemptive rule under Section 16 of the Exchange Act (including any amendment to Rule 16b-3 of the Exchange Act) that are requirements for the application of such exemptive rule. To the extent permitted by Applicable Law, this Agreement shall be deemed amended to the extent necessary to conform to such applicable exemptive rule.

  3.14 Not a Contract of Service Relationship. Nothing in this Agreement or in the Plan shall confer upon Participant any right to continue to serve as an employee or other service provider of the Company or any of its Subsidiaries or interfere with or restrict in any way with the right of the Company or any of its Subsidiaries, which rights are hereby expressly reserved, to discharge or to terminate for any reason whatsoever, with or without cause, the services of the Participant’s at any time.

  3.15 Entire Agreement. The Plan, the Grant Notice, and this Agreement (including all Exhibits thereto, if any) constitute the entire agreement of the parties and supersede in their entirety all prior undertakings and agreements of the Company and the Participant with respect to the subject matter hereof.

  3.16 Section 409A. This Award is not intended to constitute “nonqualified deferred compensation” within the meaning of Section 409A of the Code (together with any Department of Treasury regulations and other interpretive guidance issued thereunder, including without limitation any such regulations or other guidance that may be issued after the date hereof, “Section 409A”). However, notwithstanding any other provision of the Plan, the Grant Notice or this Agreement, if at any time the Administrator determines that this Award (or any portion thereof) may be subject to Section 409A, the Administrator shall have the right in its sole discretion (without any obligation to do so or to indemnify Participant or any other person for failure to do so) to adopt such amendments to the Plan, the Grant Notice or this Agreement, or adopt other policies and procedures (including amendments, policies and procedures with retroactive effect), or take any other actions, as the Administrator determines are necessary or appropriate for this Award either to be exempt from the application of Section 409A or to comply with the requirements of Section 409A.

  3.17 Limitation on Participant’s Rights. Participation in the Plan confers no rights or interests other than as herein provided. This Agreement creates only a contractual obligation on the part of the Company as to amounts payable and shall not be construed as creating a trust. Neither the Plan nor any underlying program, in and of itself, has any assets. The Participant shall have only the rights of a general unsecured creditor of the Company and its Subsidiaries with respect to amounts credited and benefits payable, if any, with respect to the RSUs, and rights no greater than the right to receive the Common Stock as a general unsecured creditor with respect to RSUs, as and when payable hereunder.

  - 6 -Exhibit
4.2

 

DESCRIPTION
OF THE REGISTRANT’S SECURITIES REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934

  

As
of March 21, 2022, Mawson Infrastructure Group Inc. (the “Company”, “we”, “us” or “our”)
has one class of securities registered under Section 12 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”),
which is our Common Stock, par value $0.001 per share (the “Common Stock”). The Common Stock is currently listed on the Nasdaq
Stock Market and trades under the symbol “MIGI.” The following is a summary of some of the terms of the Company’s Common
Stock. This summary is not complete and is subject to and qualified in its entirety by reference to the Company’s Restated Certificate
of Incorporation, as amended (the “Certificate of Incorporation”), and Amended and Restated Bylaws (the “Bylaws”).
The terms of the Common Stock are also subject to and qualified by the Delaware General Corporation Law (“DGCL”). We urge
you to read the applicable provisions of the DGCL, our Certificate of Incorporation and our Bylaws.

 

Authorized
Capital Stock

 

Under
our Certificate of Incorporation, we are authorized to issue up to one hundred twenty million (120,000,000) shares of Common Stock, and
one million (1,000,000) shares of preferred stock.

 

Common
Stock

 

Holders
of our Common Stock are entitled to one vote for each share held on all matters submitted to a vote of our stockholders. Holders of our
Common Stock have no cumulative voting rights. Further, holders of our Common Stock have no preemptive or conversion rights or other
subscription rights. Upon our liquidation, dissolution or winding-up, holders of our Common Stock are entitled to share in all assets
remaining after payment of all liabilities and the liquidation preferences of any of our outstanding shares of preferred stock. Subject
to preferences that may be applicable to any outstanding shares of preferred stock, holders of our Common Stock are entitled to receive
dividends, if any, as may be declared from time to time by our Board of Directors (the “Board”) out of our assets
which are legally available. Such dividends, if any, are payable in cash, in property or in shares of capital stock.

 

The
holders of shares of our Common Stock that are entitled to cast at least 331⁄3 of the total votes entitled to be cast by the holders
of all of our outstanding capital stock, present in person or by proxy, are necessary to constitute a quorum at any meeting. If a quorum
is present, an action by stockholders entitled to vote on a matter is approved if the number of votes cast in favor of the action exceeds
the number of votes cast in opposition to the action, with the exception of the election of directors, which requires a plurality of
the votes cast, represented in person or by proxy, necessary to constitute a quorum for the transaction of business at any meeting. If
a quorum is present, an action by stockholders entitled to vote on a matter is approved if the number of votes cast in favor of the action
exceeds the number of votes cast in opposition to the action, with the exception of the election of directors, which requires a plurality
of the votes cast.

 

Anti-Takeover
Provisions of Delaware Law, Our Certificate of Incorporation and Bylaws

 

The
provisions of Delaware law, our Certificate of Incorporation and our Bylaws could discourage or make it more difficult to accomplish
a proxy contest or other change in our management or the acquisition of control by a holder of a substantial amount of our voting stock.
It is possible that these provisions could make it more difficult to accomplish, or could deter, transactions that stockholders may otherwise
consider to be in their best interests or in our best interests. These provisions are intended to enhance the likelihood of continuity
and stability in the composition of our Board and in the policies formulated by our Board and to discourage certain types of transactions
that may involve an actual or threatened change of our control. These provisions are designed to reduce our vulnerability to an unsolicited
acquisition proposal and to discourage certain tactics that may be used in proxy fights. Such provisions also may have the effect of
preventing changes in our management.

 

Delaware
Statutory Business Combinations Provision

 

Section
203 of the DGCL prohibits a publicly-held Delaware corporation from engaging in a “business combination” with an “interested
stockholder” for a period of three (3) years after the date of the transaction in which the person became an interested stockholder,
unless the business combination is, or the transaction in which the person became an interested stockholder was, approved in a prescribed
manner or another prescribed exception applies. For purposes of Section 203, a “business combination” is defined broadly
to include a merger, asset sale or other transaction resulting in a financial benefit to the interested stockholder, and, subject to
certain exceptions, an “interested stockholder” is a person who, together with his or her affiliates and associates, owns,
or within three (3) years prior, did own, 15% or more of the corporation’s voting stock. However, we elected to opt out of the
provisions of Section 203. 

 

     

     

    

 

Advance
Notice Provisions for Stockholder Proposals and Stockholder Nominations of Directors

 

Our
Bylaws provide that, for nominations to our Board or for other business to be properly brought by a stockholder before a meeting of stockholders,
the stockholder must first have given timely notice of the proposal in writing to our secretary at our principal offices. For an annual
meeting, a stockholder’s notice generally must be delivered not less than 45 days nor more than 75 days prior to the one-year anniversary
of the date on which we first mailed our proxy materials for the preceding year’s annual meeting of stockholders. For an annual
meeting, the notice must generally be delivered not later than the close of business on the later of the 90th day prior
to such annual meeting or the 10th day following the day on which public announcement is first made. Detailed requirements
as to the form of the notice and information required in the notice are specified in our Bylaws. If it is determined that business was
not properly brought before a meeting in accordance with our Bylaws, such business will not be conducted at the meeting. 

 

Special
Meetings of Stockholders

 

Special
meetings of the stockholders may be called only by either (i) the chairman of our Board, chief executive officer, or the president, (ii)
by our Board pursuant to a resolution adopted by a majority of the total number of directors which we would have if there were no vacancies,
or (iii) by the holders of 20% of the total votes entitled to be cast by the holders of all our outstanding capital stock entitled to
vote generally in an election of directors.

 

Stockholder
Action by Written Consent

 

Each
of our Certificate of Incorporation and our Bylaws permit our stockholders to act by written consent.

 

Super
Majority Stockholder Vote Required for Certain Actions

 

The
DGCL generally provides that the affirmative vote of a majority of the shares entitled to vote on any matter is required to amend a corporation’s
certificate of incorporation or bylaws, unless the corporation’s certificate of incorporation or bylaws, as the case may be, requires
a greater percentage. Our Certificate of Incorporation requires the affirmative vote of the holders of at least 661⁄3 of our outstanding
voting stock to amend or repeal any provision of our Bylaws or any amend or repeal any provision of our Certificate of Incorporation
relating to limitation of director liability, indemnification and advancement of expenses or amendments to our Certificate of Incorporation
or our Bylaws. All other provisions of our Certificate of Incorporation may be amended or repealed by a simple majority vote of our Board.

 

Dividends

 

We
have not declared any cash dividends on our Common Stock since inception and we do not anticipate paying any cash dividends on our Common
Stock in the foreseeable future.

 

Transfer
Agent and Registrar

 

The
transfer agent and registrar for our Common Stock is Computershare.

 

Stock
Market Listing

 

Our
Common Stock is currently listed on the Nasdaq Stock Market and trades under the symbol “MIGI.”

  

Certain
Effects of Authorized but Unissued Stock

 

We
have shares of Common Stock and preferred stock available for future issuance without stockholder approval. We may issue these additional
shares for a variety of corporate purposes, including future public or private offerings to raise additional capital or to facilitate
corporate acquisitions or for payment as a dividend on our capital stock. The existence of unissued and unreserved preferred stock may
enable our board of directors to issue shares of preferred stock with terms that could render more difficult or discourage a third-party
attempt to obtain control of us by means of a merger, tender offer, proxy contest or otherwise, thereby protecting the continuity of
our management. In addition, if we issue preferred stock, the issuance could adversely affect the voting power of holders of Common Stock
and the likelihood that holders of our Common Stock will receive dividend payments or payments upon liquidation.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00342-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00342-of-00352.parquet"}]]